This topic contains a solution. Click here to go to the answer

Author Question: Exophthalmos is a sign of which of the following endocrine disorders? a. Endemic goiter b. ... (Read 27 times)

silviawilliams41

  • Hero Member
  • *****
  • Posts: 560
Exophthalmos is a sign of which of the following endocrine disorders?
 
  a. Endemic goiter
  b. Thyroid carcinoma
  c. Graves disease
  d. Nodular goiter
  e. Pituitary gland hypertrophy

Question 2

Drugs that block release of a substance involved in producing allergic reactions:
 
  a. Anticoagulants
  b. Antidiabetics
  c. Anticonvulsants
  d. Antihistamines
  e. Anesthetics



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

babybsemail

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

C

Answer to Question 2

D




silviawilliams41

  • Member
  • Posts: 560
Reply 2 on: Jun 27, 2018
Thanks for the timely response, appreciate it


bdobbins

  • Member
  • Posts: 326
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library